What is Ceritinib?
Category: Prescription Drugs
Most popular types: Zykadia
Ceritinib is an orally administered product that may be used for the treatment of metastatic non-small cell lung cancer that has progressed after treatment with crizotinib (Xalkori®) and that is positive for anaplastic lymphoma kinase (ALK).
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Adenocarcinoma (non-small cell lung cancer) | 21 | 4 | |
| Lung cancer | 2 | 0 | |
| Non-small cell lung cancer | 2 | 0 | |
| Typical lung carcinoid tumor | 2 | 0 | |
| Atypical lung carcinoid tumor | 1 | 0 | |
| Lung carcinoid tumor | 1 | 0 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Why patients stopped taking Ceritinib
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Side effects too severe | 1 |
Duration
Stopped taking Ceritinib
| Duration | Patients | Percentage |
|---|---|---|
| 1 - 6 months | 1 |
What people switch to and from
Patients started taking Ceritinib after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Crizotinib (Xalkori) | 3 | |
| Bevacizumab (Avastin) | 1 | |
| Chemotherapy | 1 |
Patients stopped taking Ceritinib and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Alectinib (Alecensa) | 1 |
Last updated: